Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Works of N. Steen being referenced
A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| N. Steen | 430 | 140 | 136 | 271 | 156 | 32 | 1.0k | |
| Tor Österberg | 755 | 169 | 322 | 187 | 27 | 29 | 1.2k | |
| John S. Garrett | 99 | 45 | 94 | 120 | 129 | 39 | 1.0k | |
| Michael J. Wahl | 86 | 84 | 38 | 247 | 187 | 36 | 1.3k | |
| Elisa M. Ghezzi | 616 | 122 | 346 | 86 | 79 | 23 | 957 | |
| Constantine Oulis | 520 | 117 | 58 | 249 | 24 | 44 | 967 | |
| I. Soh | 534 | 117 | 169 | 89 | 74 | 20 | 910 | |
| Tommy Nederfors | 780 | 83 | 619 | 60 | 64 | 29 | 1.2k | |
| Anna Holm | 345 | 211 | 32 | 120 | 69 | 46 | 932 | |
| Inho Soh | 299 | 111 | 318 | 70 | 46 | 48 | 877 | |
| Barbara Sheller | 459 | 148 | 26 | 195 | 46 | 45 | 935 |
All Works
Loading papers...